
Number of publications published per year by Trevisani, Franco. (Source : PubMed)

Distribution of publications types for Trevisani, Franco. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Transarterial chemoembolization in Child-Pugh class B patients with hepatocellular carcinoma: between the devil and the deep blue sea.
Liver Int.
2010
Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience.
Gut
2010;59;3
Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma.
Aliment. Pharmacol. Ther.
2010;31;4
Hepatocellular carcinoma in non-cirrhotic liver: A reappraisal.
Dig Liver Dis
2009
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Eur J Gastroenterol Hepatol
2009;21;10
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia.
Gut
2009;58;8

"Torsade de pointes" during amiodarone infusion in a cirrhotic woman with a prolonged QT interval.
Dig Liver Dis
2009;41;7
Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis.
Gastroenterology
2009;137;1

Hepatocellular carcinoma in patients with cryptogenic cirrhosis.
Clin. Gastroenterol. Hepatol.
2009;7;5
Hepatocellular carcinoma in patients with cryptogenic cirrhosis.
Clin. Gastroenterol. Hepatol.
2009
[ See timeline ] [ See all publications ]
means that Trevisani, Franco has 33 papers cited a least 33 times - methodology
Dipartimento di Medicina Clinica, Alma Mater Studiorum-Università di Bologna, Semeiotica Medica, via Albertoni 15, Bologna 40138, Italy.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.